Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Filings indexed 2,553 across all filing types
Latest filing 2017-09-14 Regulatory Filings
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Appendix 4G - Key to Disclosures 9 pages 102.4KB
Regulatory Filings
2017-09-14 English
Notice of AGM/Proxy Form & Shareholder Questions 31 pages 4.4MB
Regulatory Filings
2017-09-14 English
Annual Report to Shareholders 132 pages 5.8MB
Regulatory Filings
2017-09-14 English
Retirement of Director 1 page 45.7KB
Regulatory Filings
2017-09-14 English
FDA Approves Privigen for CIDP Indication 2 pages 57.2KB
Regulatory Filings
2017-09-14 English
Change to Company Details 6 pages 393.5KB
Regulatory Filings
2017-09-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.